Cargando…

Long‐Term Fate of the Truncal Valve

BACKGROUND: Long‐term survival in patients with truncus arteriosus is favorable, but there remains significant morbidity associated with ongoing reinterventions. We aimed to study the long‐term outcomes of the truncal valve and identify risk factors associated with truncal valve intervention. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Gellis, Laura, Binney, Geoffrey, Alshawabkeh, Laith, Lu, Minmin, Landzberg, Michael J., Mayer, John E., Mullen, Mary P., Valente, Anne Marie, Sleeper, Lynn A., Brown, David W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763736/
https://www.ncbi.nlm.nih.gov/pubmed/33161813
http://dx.doi.org/10.1161/JAHA.120.019104
_version_ 1783628089122619392
author Gellis, Laura
Binney, Geoffrey
Alshawabkeh, Laith
Lu, Minmin
Landzberg, Michael J.
Mayer, John E.
Mullen, Mary P.
Valente, Anne Marie
Sleeper, Lynn A.
Brown, David W.
author_facet Gellis, Laura
Binney, Geoffrey
Alshawabkeh, Laith
Lu, Minmin
Landzberg, Michael J.
Mayer, John E.
Mullen, Mary P.
Valente, Anne Marie
Sleeper, Lynn A.
Brown, David W.
author_sort Gellis, Laura
collection PubMed
description BACKGROUND: Long‐term survival in patients with truncus arteriosus is favorable, but there remains significant morbidity associated with ongoing reinterventions. We aimed to study the long‐term outcomes of the truncal valve and identify risk factors associated with truncal valve intervention. METHODS AND RESULTS: We retrospectively reviewed patients who underwent initial truncus arteriosus repair at our institution from 1985 to 2016. Analysis was performed on the 148 patients who were discharged from the hospital and survived ≥30 days postoperatively using multivariable competing risks Cox regression modeling. Median follow‐up time was 12.6 years (interquartile range, 5.0–22.1 years) after discharge from full repair. Thirty patients (20%) underwent at least one intervention on the truncal valve during follow‐up. Survival at 1, 10, and 20 years was 93.1%, 87.0%, and 80.9%, respectively. The cumulative incidence of any truncal valve intervention by 20 years was 25.6%. Independent risk factors for truncal valve intervention included moderate or greater truncal valve regurgitation (hazard ratio [HR], 4.77; P<0.001) or stenosis (HR, 4.12; P<0.001) before full truncus arteriosus repair and moderate or greater truncal valve regurgitation at discharge after full repair (HR, 8.60; P<0.001). During follow‐up, 33 of 134 patients (25%) progressed to moderate or greater truncal valve regurgitation. A larger truncal valve root z‐score before truncus arteriosus full repair and during follow‐up was associated with worsening truncal valve regurgitation. CONCLUSIONS: Long‐term rates of truncal valve intervention are significant. At least moderate initial truncal valve stenosis and initial or residual regurgitation are independent risk factors associated with truncal valve intervention. Larger truncal valve root z‐score is associated with significant truncal valve regurgitation and may identify a subset of patients at risk for truncal valve dysfunction over time.
format Online
Article
Text
id pubmed-7763736
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-77637362020-12-28 Long‐Term Fate of the Truncal Valve Gellis, Laura Binney, Geoffrey Alshawabkeh, Laith Lu, Minmin Landzberg, Michael J. Mayer, John E. Mullen, Mary P. Valente, Anne Marie Sleeper, Lynn A. Brown, David W. J Am Heart Assoc Original Research BACKGROUND: Long‐term survival in patients with truncus arteriosus is favorable, but there remains significant morbidity associated with ongoing reinterventions. We aimed to study the long‐term outcomes of the truncal valve and identify risk factors associated with truncal valve intervention. METHODS AND RESULTS: We retrospectively reviewed patients who underwent initial truncus arteriosus repair at our institution from 1985 to 2016. Analysis was performed on the 148 patients who were discharged from the hospital and survived ≥30 days postoperatively using multivariable competing risks Cox regression modeling. Median follow‐up time was 12.6 years (interquartile range, 5.0–22.1 years) after discharge from full repair. Thirty patients (20%) underwent at least one intervention on the truncal valve during follow‐up. Survival at 1, 10, and 20 years was 93.1%, 87.0%, and 80.9%, respectively. The cumulative incidence of any truncal valve intervention by 20 years was 25.6%. Independent risk factors for truncal valve intervention included moderate or greater truncal valve regurgitation (hazard ratio [HR], 4.77; P<0.001) or stenosis (HR, 4.12; P<0.001) before full truncus arteriosus repair and moderate or greater truncal valve regurgitation at discharge after full repair (HR, 8.60; P<0.001). During follow‐up, 33 of 134 patients (25%) progressed to moderate or greater truncal valve regurgitation. A larger truncal valve root z‐score before truncus arteriosus full repair and during follow‐up was associated with worsening truncal valve regurgitation. CONCLUSIONS: Long‐term rates of truncal valve intervention are significant. At least moderate initial truncal valve stenosis and initial or residual regurgitation are independent risk factors associated with truncal valve intervention. Larger truncal valve root z‐score is associated with significant truncal valve regurgitation and may identify a subset of patients at risk for truncal valve dysfunction over time. John Wiley and Sons Inc. 2020-11-09 /pmc/articles/PMC7763736/ /pubmed/33161813 http://dx.doi.org/10.1161/JAHA.120.019104 Text en © 2020 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
Gellis, Laura
Binney, Geoffrey
Alshawabkeh, Laith
Lu, Minmin
Landzberg, Michael J.
Mayer, John E.
Mullen, Mary P.
Valente, Anne Marie
Sleeper, Lynn A.
Brown, David W.
Long‐Term Fate of the Truncal Valve
title Long‐Term Fate of the Truncal Valve
title_full Long‐Term Fate of the Truncal Valve
title_fullStr Long‐Term Fate of the Truncal Valve
title_full_unstemmed Long‐Term Fate of the Truncal Valve
title_short Long‐Term Fate of the Truncal Valve
title_sort long‐term fate of the truncal valve
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763736/
https://www.ncbi.nlm.nih.gov/pubmed/33161813
http://dx.doi.org/10.1161/JAHA.120.019104
work_keys_str_mv AT gellislaura longtermfateofthetruncalvalve
AT binneygeoffrey longtermfateofthetruncalvalve
AT alshawabkehlaith longtermfateofthetruncalvalve
AT luminmin longtermfateofthetruncalvalve
AT landzbergmichaelj longtermfateofthetruncalvalve
AT mayerjohne longtermfateofthetruncalvalve
AT mullenmaryp longtermfateofthetruncalvalve
AT valenteannemarie longtermfateofthetruncalvalve
AT sleeperlynna longtermfateofthetruncalvalve
AT browndavidw longtermfateofthetruncalvalve